Literature DB >> 28654869

A review of high performance liquid chromatographic-mass spectrometric urinary methods for anticancer drug exposure of health care workers.

Patricia I Mathias1, Thomas H Connor2, Clayton B'Hymer2.   

Abstract

This review describes published high performance liquid chromatography/mass spectrometry (HPLC-MS) methods for the determination of anticancer drugs in human urine as non-invasive tool for monitoring of health care worker exposure to antineoplastic and cytotoxic drugs. HPLC-MS is a sensitive and specific method for analysis of anticancer drugs and their metabolites in biological fluids. In this review, a tabular summary and overview of published HPLC-MS methods are presented, as well as future trends and limitations in this area of research. Published by Elsevier B.V.

Entities:  

Keywords:  Anticancer drugs; Antineoplastic drug; Liquid chromatography mass spectrometry; Occupational biomonitoring; Urinary biomarker

Mesh：

Substances：

Year:  2017        PMID： 28654869      PMCID： PMC5585056          DOI： 10.1016/j.jchromb.2017.06.028

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN： 1570-0232            Impact factor:   3.205


  49 in total

1.  Combined quantification of paclitaxel, docetaxel and ritonavir in human feces and urine using LC-MS/MS.

Authors:  Jeroen J M A Hendrikx; Hilde Rosing; Alfred H Schinkel; Jan H M Schellens; Jos H Beijnen
Journal:  Biomed Chromatogr       Date:  2013-08-29       Impact factor: 1.902

2.  Validation protocol and analytical quality in biological monitoring of occupational exposure to antineoplastic drugs.

Authors:  Roberta Turci; Cristina Sottani; Rudolf Schierl; Claudio Minoia
Journal:  Toxicol Lett       Date:  2005-10-24       Impact factor: 4.372

Review 3.  Liquid chromatography-mass spectrometry for the quantitative bioanalysis of anticancer drugs.

Authors:  Ellen Stokvis; Hilde Rosing; Jos H Beijnen
Journal:  Mass Spectrom Rev       Date:  2005 Nov-Dec       Impact factor: 10.946

4.  Association of surface contamination by antineoplastic drugs with different working conditions in hospital pharmacies.

Authors:  Pavel Odraska; Lenka Dolezalova; Jan Kuta; Michal Oravec; Pavel Piler; Stanislav Synek; Ludek Blaha
Journal:  Arch Environ Occup Health       Date:  2014       Impact factor: 1.663

Review 5.  Recent advances in application of hydrophilic interaction chromatography for quantitative bioanalysis.

Authors:  Wenying Jian; Richard W Edom; Yaodong Xu; Naidong Weng
Journal:  J Sep Sci       Date:  2010-03       Impact factor: 3.645

6.  Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine.

Authors:  A C Dubbelman; M Tibben; H Rosing; A Gebretensae; L Nan; S H Gorman; P Robertson; J H M Schellens; J H Beijnen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-03-03       Impact factor: 3.205

Review 7.  Quantification of taxanes in biological matrices: a review of bioanalytical assays and recommendations for development of new assays.

Authors:  J J M A Hendrikx; H Rosing; A H Schinkel; J H M Schellens; J H Beijnen
Journal:  Bioanalysis       Date:  2014-04       Impact factor: 2.681

8.  Simultaneous determination of low levels of methotrexate and cyclophosphamide in human urine by micro liquid chromatography/electrospray ionization tandem mass spectrometry.

Authors:  Anna Barbieri; Laura Sabatini; Paolo Indiveri; Roberta Bonfiglioli; Vittorio Lodi; Francesco S Violante
Journal:  Rapid Commun Mass Spectrom       Date:  2006       Impact factor: 2.419

9.  Trace determination of anthracyclines in urine: a new high-performance liquid chromatography/tandem mass spectrometry method for assessing exposure of hospital personnel.

Authors:  Cristina Sottani; Giovanna Tranfo; Maurizio Bettinelli; Paolo Faranda; Mariangela Spagnoli; Claudio Minoia
Journal:  Rapid Commun Mass Spectrom       Date:  2004       Impact factor: 2.419

10.  A HPLC-SRM-MS based method for the detection and quantification of methotrexate in urine at doses used in clinical practice for patients with rheumatological disease: a potential measure of adherence.

Authors:  J Bluett; I Riba-Garcia; K Hollywood; S M M Verstappen; A Barton; R D Unwin
Journal:  Analyst       Date:  2015-03-21       Impact factor: 4.616
View more
  5 in total

1.  Application of an innovative high-throughput liquid chromatography-tandem mass spectrometry method for simultaneous analysis of 18 hazardous drugs to rule out accidental acute chemotherapy exposures in health care workers.

Authors:  Pan Shu; Ting Zhao; Bo Wen; Kari Mendelsohn-Victor; Duxin Sun; Christopher R Friese; Manjunath P Pai
Journal:  J Oncol Pharm Pract       Date:  2019-09-04       Impact factor: 1.809

2.  Evaluation of apoptosis induced by exposure to antineoplastic drugs in peripheral blood lymphocytes of nurses.

Authors:  Heng Liao; Lijie Bi; Jun Wei; Xin Song
Journal:  Mol Med Rep       Date:  2017-09-22       Impact factor: 2.952

Review 3.  Analytical methodologies for determination of methotrexate and its metabolites in pharmaceutical, biological and environmental samples.

Authors:  Forough Karami; Sara Ranjbar; Younes Ghasemi; Manica Negahdaripour
Journal:  J Pharm Anal       Date:  2019-06-20

4.  Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study.

Authors:  Antoine Villa; Mathieu Molimard; Emmanuelle Bignon; Béatrice Martinez; Magali Rouyer; Simone Mathoulin-Pelissier; Isabelle Baldi; Catherine Verdun-Esquer; Mireille Canal-Raffin
Journal:  BMJ Open       Date:  2019-11-10       Impact factor: 2.692

Review 5.  Exposure to Antineoplastic Drugs in Occupational Settings: A Systematic Review of Biological Monitoring Data.

Authors:  Veruscka Leso; Cristina Sottani; Carolina Santocono; Francesco Russo; Elena Grignani; Ivo Iavicoli
Journal:  Int J Environ Res Public Health       Date:  2022-03-21       Impact factor: 3.390
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.